Delivery Order SPE2DB20D2104-SPE2DB23FS90H
- Not listed
- This federal contract award is for the supply of SHINGRIX vial kits to the Defense Logistics Agency (DLA), a defense agency. The $5,140.10 firm-fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on December 4, 2024. The contract has an ultimate completion date of December 5, 2024 and is not designated as a set-aside. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical through November...
- This federal contract award is for the delivery of SHINGRIX vial kits to the Defense Logistics Agency (DLA). The $1,987.36 firm fixed-price contract was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award represents a delivery order under a larger indefinite delivery contract (IDC) between AmerisourceBergen and the DLA, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a...
- This federal contract award is for the delivery of SHINGRIX vial kits to the Defense Logistics Agency (DLA), a defense agency under the U.S. Department of Defense. The contract, valued at $4,556.72, was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Firm Fixed Price Delivery Order with a completion date of March 6, 2025. The contract is not designated as a set-aside award. In addition to this specific contract,...
- This federal contract award is for the delivery of SHINGRIX vial kits to the Defense Logistics Agency (DLA), a component of the Department of Defense (DoD). The contract was awarded to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor, for a fixed-price delivery order with a ceiling value of $8,521.64. The contract has an ultimate completion date of September 9, 2024. AmerisourceBergen holds several Indefinite Delivery Contracts (IDCs) with the DLA and other federal...
- This federal contract award is for the delivery of SHINGRIX vial kits, a vaccine product, to the Defense Logistics Agency (DLA) Troop Support Medical. The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, in the amount of $10,690.10 with a completion date of January 26, 2023. This is a delivery order under Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with the DLA, valued at up to $999,999,999.00, which serves as the primary vehicle for...
- This federal contract award is for the delivery of Shingrix vial kits to the Defense Logistics Agency (DLA), a defense agency within the U.S. Department of Defense. The contract, valued at $6,813.30, was awarded to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract has a completion date of May 19, 2023 and is a firm fixed-price delivery order with no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is a major pharmaceutical...
- This federal contract award is for the delivery of SHINGRIX vial kits to the Defense Logistics Agency (DLA), a component of the U.S. Department of Defense. The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $2,900.24 and was awarded on February 8, 2022, with a completion date of February 9, 2022. This appears to be a delivery order issued under a larger Indefinite Delivery Contract (IDC)...
- This federal contract award is for the delivery of SHINGRIX vial kits to the Defense Logistics Agency (DLA). The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order under a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 between Amerisourcebergen's parent company, Cencora, Inc., and the DLA Troop Support Medical. This IDC serves as the primary vehicle for...
- This federal contract award is for the delivery of SHINGRIX Vial Kits to the Defense Logistics Agency (DLA) Troop Support Medical. The $6,503.09 firm-fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, on May 8, 2023. The contract has an ultimate completion date of May 9, 2023 and does not have a set-aside designation. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with...
- This federal contract award is for the delivery of SHINGRIX VIAL KITS to the Defense Logistics Agency (DLA). The $2,850.45 firm fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, on July 29, 2022. The contract has an ultimate completion date of August 1, 2022 and was not designated as a set-aside award. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- SPE2DB20D2104Indefinite Delivery Contract
- SPE2DB20D2104-SPE2DB23FS90HDelivery Order
This federal contract award is for the delivery of SHINGRIX vial kits to the Defense Logistics Agency (DLA), a defense agency within the U.S. Department of Defense. The contract was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, and has a ceiling value of $1,069.01. The contract is a delivery order with a firm fixed-price pricing type and an ultimate completion date of April 5, 2023. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The company also maintains a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at $750,000 through May 2024, which covers similar medical products and prescription drugs. This contract award does not have a set-aside designation, indicating open competition. The primary contracting agency is the DLA, which is responsible for providing logistics, acquisition, and technical services to the U.S. military, other federal agencies, and international partners.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.1k | 4/4/23 |